Telbivudine: A new treatment for chronic hepatitis B

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 46

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2007; 13(46): 6150-6155
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6150

Table 4 Efficacy at 2 yr against virological suppression (PCR negative) at 24 wk in HBeAg positive and negative individuals in the Globe study

Citation: Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6150

Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155 [PMID: 18069753 DOI: 10.3748/wjg.v13.i46.6150]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.